KALV logo

KalVista Pharmaceuticals (KALV)

Profile

Full Name

KalVista Pharmaceuticals, Inc.

Ticker Symbol

KALV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 9, 2015

Indexes

Not included

Website

http://www.kalvista.com

Employees

150

Key Details

Price

$11.69(-2.75%)

Market cap

$581.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.44(-3.30% YoY)

PE ratio

-

Next earnings date

Jul 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$11.69
KALV price is $11.69

30-Day Relative Volume

0.94
KALV 30-day relative volume is 0.94

Price Performance

Price Today change

-2.75%
KALV price is down -2.75% today

Price YTD change

+38.02%
KALV price is up +38.02% since January 1st

Price 1-year change

-1.6%
KALV price is down -1.6% year-on-year

Price 3-year change

-18.59%
KALV price is down -18.59% over the past 3 years

Price Range

Price All-time high

$129.11
KALV price is currently -90.95% below its historical high of $129.11

Price 3-year low

$4.12
KALV price is currently +183.74% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$581.18M
KALV market capitalization is $581.18 million

Market cap 3-year change

+64.9%
KALV market capitalization is up +64.9% over the past 3 years

Market cap All-time high

$1.02B
KALV market capitalization is currently -42.96% below its historical high of $1.02 billion

Market cap sector rank

71.38%
KALV market capitalization is higher than 71.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.84%
KALV shares outstanding is up +17.84% year-on-year

Shares Outstanding 3-Year Change

+102.56%
KALV shares outstanding is up +102.56% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
KALV beta is 0.87

200-day SMA

$11.07
KALV price is currently +5.56% above its 200-day simple moving average

50-day SMA

$11.13
KALV price is currently +5.02% above its 50-day simple moving average

RSI

55.91
KALV 14-day relative strength index is 55.91

Volume

0.94
KALV 30-day relative volume is 0.94

ATR

$0.94
KALV average true range is $0.94

10-day Historical Volatility

93.59%
KALV 10-day historical volatility is 93.59%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
KALV annual revenue value is unknown

Revenue Analysts estimate

-
KALV annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
KALV annual revenue 1-year change is unknown

Revenue Sector rank

-
KALV annual revenue is unknown

EPS

EPS

-$3.44
KALV annual earnings per share is -$3.44

EPS Analysts estimate

-$3.56
KALV annual earnings per share is currently -3.37% lower than the consensus analysts' forecast

EPS 1-year change

-3.3%
KALV annual earnings per share is down -3.3% year-on-year

EPS Sector rank

26.01%
KALV annual earnings per share is higher than 26.01% of companies in Healthcare sector

Profit

Gross profit

-
KALV annual gross profit value is unknown

Gross margin

-
KALV annual gross profit margin value is unknown

Operating profit

-$131.99M
KALV annual operating income is -$131.99 million

Operating margin

-
KALV annual operating profit margin value is unknown

Net income

-$126.64M
KALV annual net profit is -$126.64 million

Net margin

-
KALV annual net profit margin value is unknown

Expenses

Total expenses

$131.99M
KALV annual total expenses is $131.99 million

Operating expenses

$131.99M
KALV annual total operating expenses is $131.99 million

Cost of goods sold

-
KALV annual cost of goods sold value is unknown

Selling, general & administrative expenses

$54.28M
KALV annual SGA is $54.28 million

Depreciation and amortization

$816.00K
KALV annual depreciation & amortization is $816.00 thousand

Interest expense

-
KALV annual interest expense value is unknown

Income tax

$0.00
KALV annual income tax is $0.00

EBIT & EBITDA

EBIT

-$131.99M
KALV annual earnings before interest & taxes is -$131.99 million

EBITDA

-$131.18M
KALV annual EBITDA is -$131.18 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$235.40M
KALV annual total assets is $235.40 million

Non current assets

$9.71M
KALV annual long term assets is $9.71 million

Current assets

$225.69M
KALV annual total current assets is $225.69 million

Cash and cash equivalents

$31.79M
KALV annual cash & cash equivalents is $31.79 million

Accounts receivable

-
KALV annual accounts receivable value is unknown

Inventory

-
KALV annual inventory value is unknown

Liabilities

Total liabilities

$28.82M
KALV annual total liabilities is $28.82 million

Long term liabilities

$6.01M
KALV annual total long term liabilities is $6.01 million

Current liabilities

$22.81M
KALV annual total current liabilities is $22.81 million

Accounts payable

$9.11M
KALV annual accounts payable is $9.11 million

Debt

Total debt

$7.32M
KALV annual total debt is $7.32 million

Total debt 1-year change

-11.12%
KALV annual total debt is down -11.12% year-on-year

Long term debt

$6.01M
KALV annual long term debt is $6.01 million

Short term debt

$1.30M
KALV annual short term debt is $1.30 million

Equity & Capital

Shareholders equity

$206.58M
KALV annual stockholders equity is $206.58 million

Book value

$206.58M
KALV annual book value is $206.58 million

Retained earnings

-$469.73M
KALV annual retained earnings is -$469.73 million

Working capital

$202.88M
KALV annual working capital is $202.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$89.23M
KALV annual cash flow from operations is -$89.23 million

Cash from operations 1-year change

-18.56%
KALV annual cash flow from operations is down -18.56% year-on-year

Cash from investing

-$84.72M
KALV annual cash flow from investing activities is -$84.72 million

Cash from investing 1-year change

-304.56%
KALV annual cash flow from investing activities is down -304.56% year-on-year

Cash from financing

$150.71M
KALV annual cash flow from financing activities is $150.71 million

Cash from financing 1-year change

+159.33%
KALV annual cash flow from financing activities is up +159.33% year-on-year

CAPEX

CAPEX

-
KALV annual capital expenditures value is unknown

CAPEX 1-year change

-
KALV annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$89.67M
KALV annual free cash flow is -$89.67 million

Free cash flow 1-year change

-17.29%
KALV annual free cash flow is down -17.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
KALV annual gross profit margin value is unknown

Operating margin

-
KALV annual operating profit margin value is unknown

Net margin

-
KALV annual net profit margin value is unknown

ROA & ROE

ROA

-53.80%
KALV annual return on assets is -53.80%

ROE

-61.30%
KALV annual return on equity is -61.30%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KALV price to earnings ratio value is unknown

PE ratio Sector rank

-
KALV price to earnings ratio is unknown

PB Ratio

PB ratio

4.00
KALV price to book ratio is 4.00

PB ratio Sector rank

79.42%
KALV price to book ratio is higher than 79.42% of companies in Healthcare sector

PS Ratio

PS ratio

-
KALV price to sales ratio value is unknown

PS ratio Sector rank

-
KALV price to sales ratio is unknown

Enterprise value

Enterprise value

$419.67M
KALV enterprise value is $419.67 million

Enterprise value Sector rank

67.33%
KALV enterprise value is higher than 67.33% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.32
KALV EV/EBITDA is -2.32

EV/EBITDA Sector rank

29.77%
KALV EV/EBITDA is higher than 29.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.90
KALV annual current ratio is 9.90

Quick ratio

-
KALV annual quick ratio value is unknown

Leverage

Debt to equity

0.04
KALV annual debt to equity ratio is 0.04

Interest coverage ratio

-
KALV annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
KALV piotroski f-score value is unknown

Altman Z-Score

-
KALV altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Mar 26, 25 Needham
Buy
Mar 26, 25 Jones Trading
Buy
Mar 26, 25 Citizens Capital Markets
Market Outperform
Mar 14, 25 HC Wainwright & Co.
Buy
Mar 13, 25 Needham
Buy
Mar 3, 25 Citizens Capital Markets
Market Outperform
Jan 31, 25 JMP Securities
Market Outperform
Jan 7, 25 TD Cowen
Buy
Dec 18, 24 B of A Securities
Buy

Institutional Ownership

Similar stocks

PRAX logo
Praxis Precision Medicines (PRAX)
TRVI logo
Trevi Therapeutics (TRVI)
REPL logo
Replimune (REPL)
RXST logo
RxSight (RXST)
ABUS logo
Arbutus Biopharma (ABUS)
FLGT logo
Fulgent Genetics (FLGT)
CSTL logo
Castle Biosciences (CSTL)
BFLY logo
Butterfly Network (BFLY)
DNTH logo
Dianthus Therapeutics (DNTH)
  • What is the ticker symbol for KalVista Pharmaceuticals?
  • Does KalVista Pharmaceuticals pay dividends?
  • What sector is KalVista Pharmaceuticals in?
  • What industry is KalVista Pharmaceuticals in?
  • What country is KalVista Pharmaceuticals based in?
  • When did KalVista Pharmaceuticals go public?
  • Is KalVista Pharmaceuticals in the S&P 500?
  • Is KalVista Pharmaceuticals in the NASDAQ 100?
  • Is KalVista Pharmaceuticals in the Dow Jones?
  • When was KalVista Pharmaceuticals's last earnings report?
  • When does KalVista Pharmaceuticals report earnings?
  • Should I buy KalVista Pharmaceuticals stock now?

What is the ticker symbol for KalVista Pharmaceuticals?

The ticker symbol for KalVista Pharmaceuticals is NASDAQ:KALV

Does KalVista Pharmaceuticals pay dividends?

No, KalVista Pharmaceuticals does not pay dividends

What sector is KalVista Pharmaceuticals in?

KalVista Pharmaceuticals is in the Healthcare sector

What industry is KalVista Pharmaceuticals in?

KalVista Pharmaceuticals is in the Biotechnology industry

What country is KalVista Pharmaceuticals based in?

KalVista Pharmaceuticals is headquartered in United States

When did KalVista Pharmaceuticals go public?

KalVista Pharmaceuticals's initial public offering (IPO) was on April 9, 2015

Is KalVista Pharmaceuticals in the S&P 500?

No, KalVista Pharmaceuticals is not included in the S&P 500 index

Is KalVista Pharmaceuticals in the NASDAQ 100?

No, KalVista Pharmaceuticals is not included in the NASDAQ 100 index

Is KalVista Pharmaceuticals in the Dow Jones?

No, KalVista Pharmaceuticals is not included in the Dow Jones index

When was KalVista Pharmaceuticals's last earnings report?

KalVista Pharmaceuticals's most recent earnings report was on Mar 12, 2025

When does KalVista Pharmaceuticals report earnings?

The next expected earnings date for KalVista Pharmaceuticals is Jul 11, 2025

Should I buy KalVista Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page